World Arthritis Day (https://www.eular.org/world_arthritis_day.cfm) was established in 1996 and is intended to draw attention to and increase knowledge of rheumatic diseases among healthcare providers, decision-makersand the general public.
There are several Swedish companies developing new treatments for rheumatism. Two of these are Umeå-based Lipum and Malmö-based Cyxone, that develop drug candidates SOL-116 and Rabeximod respectively, both with the ambition to inhibit inflammation and alleviate the painful symptoms.
Read the article here.